SCHEMBL7648050

SCHEMBL7648050

COc1cc(N(C(C)=O)c2ccc([C@@H](CC(=O)O)NC(=O)c3cccnc3)cc2)ccc1NC(=O)Nc1ccccc1C

nearest known ligand 0.45

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
ITGB1 P05556 6/20 0.45
ITGA4 P13612 6/20 0.45
CTSA P10619 7/20 0.45
POLB P06746 1/20 0.45
TSHR P16473 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
MAPT P10636 1/20 0.43
ITGB7 P26010 1/20 0.42
CYP2C19 P33261 1/20 0.41
GFER P55789 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7390822 1.00 ITGB1 (0.45) ITGB1ITGA4CTSAPOLBTSHR
Trifluoroacetic Acid SCHEMBL5701085 0.96 ITGB1 (0.42) ITGB1ITGA4CTSAPOLBTSHR
SCHEMBL7651698 0.92 ITGB1 (0.49) ITGB1ITGA4CTSASMN1; SMN2MAPT
SCHEMBL7651701 0.92 ITGB1 (0.49) ITGB1ITGA4CTSASMN1; SMN2MAPT
SCHEMBL7646244 0.89 ITGA4 (0.47) ITGB1ITGA4CTSASMN1; SMN2ITGB7
SCHEMBL7646241 0.89 ITGA4 (0.47) ITGB1ITGA4CTSASMN1; SMN2ITGB7
SCHEMBL7645886 0.88 ITGB1 (0.44) ITGB1ITGA4CTSASMN1; SMN2ITGB7
SCHEMBL7389044 0.88 ITGB1 (0.44) ITGB1ITGA4CTSASMN1; SMN2ITGB7
SCHEMBL7422471 0.88 ITGB1 (0.49) ITGB1ITGA4CTSAPOLBMAPT
SCHEMBL7644620 0.88 ITGB1 (0.49) ITGB1ITGA4CTSAPOLBMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6479519-B1 INHIBITORS OF CELL ADHESION; TREATMENT OF ASTHMA OR INFLAMMATORY BOWEL DISEASE AVENTIS PHARMA LIMITED (GB) 2002-11-12 US claimed
US-6479519-B1 INHIBITORS OF CELL ADHESION; TREATMENT OF ASTHMA OR INFLAMMATORY BOWEL DISEASE AVENTIS PHARMA LIMITED (GB) 2002-11-12 US disclosed